CME Group (CME) Stock Forecast & Price Target

$238.53 +1.71 (+0.72%)

(As of 12/20/2024 05:51 PM ET)

CME Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Hold

Based on 15 Analyst Ratings

Sell
4

Hold
7

Buy
4

Based on 15 Wall Street analysts who have issued ratings for CME Group in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 4 have given a sell rating, 7 have given a hold rating, and 4 have given a buy rating for CME.

Consensus Price Target

$229.33
-3.86% Downside

According to the 15 analysts' twelve-month price targets for CME Group, the average price target is $229.33. The highest price target for CME is $260.00, while the lowest price target for CME is $180.00. The average price target represents a forecasted downside of -3.86% from the current price of $238.53.

Get the Latest News and Ratings for CME and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CME Group and its competitors.

CME Analyst Ratings Over Time

Type	Current Forecast 12/22/23 to 12/21/24	1 Month Ago 11/22/23 to 11/21/24	3 Months Ago 9/23/23 to 9/22/24	1 Year Ago 12/22/22 to 12/22/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	4 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)	5 Buy rating(s)
Hold	7 Hold rating(s)	7 Hold rating(s)	4 Hold rating(s)	3 Hold rating(s)
Sell	4 Sell rating(s)	4 Sell rating(s)	4 Sell rating(s)	1 Sell rating(s)
Consensus Price Target	$229.33	$224.47	$209.73	$217.00
Forecasted Upside	-3.86% Downside	-1.10% Downside	-1.61% Downside	1.26% Upside
Consensus Rating	Hold	Hold	Reduce	Hold

Crypto’s hidden gem + greatest crypto bull run in history = $$$? (Ad)

You don’t actually want to buy Bitcoin this time around. That’s because there’s a better way to take advantage of this new bull market… One market expert calls it Crypto’s Hidden Gem And it’s a new way that has given folks like you and me the chance to see bigger and faster moves than the traditional way of buying Bitcoin… That means if you’ve stayed away from Bitcoin and crypto because it's confusing or seems risky… This is a much safer and better approach to ride this years’ crypto bull run. Because believe it or not… The 2024 crypto bull run is one you DON’T want to miss.

Click Here to get the full details about Crypto’s Hidden Gem

CME Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CME Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CME Group Stock vs. The Competition

Type	CME Group	Finance Companies	S&P 500
Consensus Rating Score	2.00	2.50	2.51
Consensus Rating	Hold	Hold	Moderate Buy
Predicted Upside	-3.86% Downside	18.66% Upside	14.54% Upside
News Sentiment Rating	Positive News See Recent CME News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
12/20/2024	Keefe, Bruyette & Woods 4 of 5 stars		Boost Target	Market Perform ➝ Market Perform	$237.00 ➝ $260.00	+9.79%
12/9/2024	Barclays 3 of 5 stars		Boost Target	Equal Weight ➝ Equal Weight	$231.00 ➝ $257.00	+7.36%
11/11/2024	Deutsche Bank Aktiengesellschaft 3 of 5 stars		Lower Target	Hold ➝ Hold	$227.00 ➝ $226.00	-0.14%
10/28/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$240.00 ➝ $250.00	+10.55%
10/24/2024	Oppenheimer Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$245.00 ➝ $258.00	+12.64%
10/24/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Sabadra Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Sector Perform ➝ Sector Perform	$235.00 ➝ $235.00	+2.60%
Get the Latest News and Ratings for CME and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for CME Group and its competitors with MarketBeat's FREE daily newsletter.
10/24/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$250.00 ➝ $255.00	+12.12%
10/17/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$210.00 ➝ $233.00	+2.02%
10/8/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	S. Clinch Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Buy ➝ Neutral	$244.00	+10.04%
10/3/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sell ➝ Sell	$195.00 ➝ $198.00	-11.89%
10/3/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underperform ➝ Underperform	$177.00 ➝ $180.00	-19.49%
9/26/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	W. Katz Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Hold	$221.00	+1.60%
7/25/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Underweight ➝ Underweight	$187.00 ➝ $191.00	-3.65%
4/25/2024	Rosenblatt Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Sell ➝ Sell	$185.00 ➝ $187.00	-12.04%
3/6/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$225.00 ➝ $245.00	+12.27%
2/7/2023	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform	$192.00 ➝ $198.00	+13.30%
1/5/2023	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target		$226.00 ➝ $220.00	+29.35%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 09:55 PM ET.

Should I Buy CME Group Stock? CME Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Thursday, December 12, 2024. Please send any questions or comments about these CME Group pros and cons to contact@marketbeat.com.

CME Group
Bull Case

Here are some ways that investors could benefit from investing in CME Group Inc.:

Recent price target increases from multiple analysts, including Barclays raising it to $257.00, indicate strong market confidence in CME Group Inc.'s growth potential.
The stock has shown resilience with a current price of $236.72, reflecting a solid performance despite market fluctuations.
Analysts have given CME Group Inc. an average rating of "Hold," suggesting that while there may not be immediate buy signals, the stock is stable and worth monitoring.
With a market capitalization of approximately $85.30 billion, CME Group Inc. is a significant player in the financial services sector, providing a level of stability and reliability for investors.
Recent upgrades from firms like Citigroup and Piper Sandler, which have set target prices above the current trading price, suggest potential for future gains.

CME Group
Bear Case

Investors should be bearish about investing in CME Group Inc. for these reasons:

Despite recent upgrades, four analysts have rated the stock with a sell rating, indicating some skepticism about its short-term performance.
The stock has experienced a decline of 1.1% recently, which may signal underlying weaknesses or market concerns.
Insider selling activity, with directors selling shares at prices around $222.92 and $226.96, could indicate a lack of confidence in the stock's near-term prospects.
The average target price from analysts is $224.47, which is below the current trading price, suggesting limited upside potential in the near term.
The company's price-to-earnings ratio of 25.17 may be considered high, indicating that the stock could be overvalued compared to its earnings, which might deter value-focused investors.

CME Forecast - Frequently Asked Questions

: According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for CME Group is $229.33, with a high forecast of $260.00 and a low forecast of $180.00.
: 15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CME Group in the last twelve months. There are currently 4 sell ratings, 7 hold ratings and 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" CME shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CME, but not buy additional shares or sell existing shares.
: According to analysts, CME Group's stock has a predicted downside of -3.86% based on their 12-month stock forecasts.
: Over the previous 90 days, CME Group's stock had 1 downgrade by analysts.
: CME Group has been rated by research analysts at Bank of America, Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Keefe, Bruyette & Woods, Morgan Stanley, Oppenheimer, Piper Sandler, Redburn Atlantic, Royal Bank of Canada, TD Cowen, and The Goldman Sachs Group in the past 90 days.
: Analysts like CME Group less than other "finance" companies. The consensus rating score for CME Group is 2.00 while the average consensus rating score for "finance" companies is 2.50. Learn more on how CME compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

Has Trump Finally Gone Too Far? (Ad)

Lately, there's been a lot of buzz around a secret loophole executive insiders are using to make millions buying and selling their own stocks. It's so powerful ... so profitable ... that most people immediately assume this is just another example of Trump doing what's best for business executives. But surprisingly, this loophole has been on the books for many years and executives have been using it to make HUNDREDS of millions of dollars. And here's the good news.

This page (NASDAQ:CME) was last updated on 12/21/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CME Group (CME) Stock Forecast & Price Target